2614 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2024
JOURNALRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
PREMIER AUTEURBorel C
TITREStandard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.
ANNÉE2024
JOURNALDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
PREMIER AUTEURBotsen D
TITRETrifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial.
ANNÉE2024
JOURNALCancer immunology, immunotherapy : CII
PREMIER AUTEURHampe L
TITREEffect of radiochemotherapy on peripheral immune response in glioblastoma.
ANNÉE2024
JOURNALGastro hep advances
PREMIER AUTEURHunaut T
TITRELong-Term Neoplastic Risk Associated With Colorectal Strictures in Crohn's Disease: A Multicenter Study.
ANNÉE2024
JOURNALThe British journal of dermatology
PREMIER AUTEURHammas K
TITREIncidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.
ANNÉE2024
JOURNALScientific reports
PREMIER AUTEURPoterszman N
TITREA bicentric retrospective study of the correlation of EAU BCR risk groups with F-PSMA-1007 PET/CT detection in prostate cancer biochemical recurrence.
ANNÉE2024
JOURNALPharmaceutics
PREMIER AUTEURBiny L
TITREFunctionalized Calcium Carbonate-Based Microparticles as a Versatile Tool for Targeted Drug Delivery and Cancer Treatment.
ANNÉE2024
JOURNALNature communications
PREMIER AUTEURGarcia-Leon MJ
TITREPlatelets favor the outgrowth of established metastases.
ANNÉE2024
JOURNALExperimental hematology & oncology
PREMIER AUTEURNotarantonio AB
TITREHighly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation.
ANNÉE2024
JOURNALCell death & disease
PREMIER AUTEURGeorgievski A
TITREValrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques